IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FENOGLIO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.075
NA - Nord America 19.642
AS - Asia 19.119
SA - Sud America 1.733
AF - Africa 440
OC - Oceania 129
Continente sconosciuto - Info sul continente non disponibili 18
Totale 61.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.768
GB - Regno Unito 6.018
CN - Cina 5.778
SG - Singapore 5.601
IT - Italia 3.311
DE - Germania 2.604
SE - Svezia 1.818
VN - Vietnam 1.613
RU - Federazione Russa 1.586
HK - Hong Kong 1.462
BD - Bangladesh 1.306
BR - Brasile 1.272
IN - India 1.102
FR - Francia 1.049
NL - Olanda 698
UA - Ucraina 677
CA - Canada 673
IE - Irlanda 598
TR - Turchia 574
KR - Corea 509
FI - Finlandia 430
JP - Giappone 303
PL - Polonia 275
EU - Europa 244
ID - Indonesia 216
DK - Danimarca 211
CO - Colombia 197
CI - Costa d'Avorio 166
ES - Italia 156
GR - Grecia 146
BE - Belgio 130
AU - Australia 111
AR - Argentina 102
MX - Messico 91
IQ - Iraq 83
ZA - Sudafrica 79
AT - Austria 77
IR - Iran 68
UZ - Uzbekistan 59
PK - Pakistan 57
CH - Svizzera 55
MA - Marocco 51
PH - Filippine 48
TW - Taiwan 42
SA - Arabia Saudita 35
MY - Malesia 34
EC - Ecuador 33
VE - Venezuela 33
AE - Emirati Arabi Uniti 31
RO - Romania 31
CZ - Repubblica Ceca 30
CL - Cile 27
JO - Giordania 24
EG - Egitto 23
NO - Norvegia 23
IL - Israele 22
PE - Perù 22
PT - Portogallo 22
PY - Paraguay 21
TN - Tunisia 21
JM - Giamaica 20
KE - Kenya 20
NP - Nepal 19
NZ - Nuova Zelanda 17
UY - Uruguay 17
DZ - Algeria 16
AZ - Azerbaigian 15
LT - Lituania 15
KZ - Kazakistan 13
LB - Libano 13
AL - Albania 12
CR - Costa Rica 12
DO - Repubblica Dominicana 12
PA - Panama 12
RS - Serbia 12
LU - Lussemburgo 11
LV - Lettonia 11
TH - Thailandia 11
HN - Honduras 10
OM - Oman 10
SN - Senegal 10
TT - Trinidad e Tobago 10
BG - Bulgaria 9
KG - Kirghizistan 9
XK - ???statistics.table.value.countryCode.XK??? 9
AM - Armenia 8
BA - Bosnia-Erzegovina 8
EE - Estonia 8
BO - Bolivia 7
BY - Bielorussia 7
HU - Ungheria 7
ET - Etiopia 6
GE - Georgia 6
GT - Guatemala 6
HR - Croazia 6
IS - Islanda 6
PR - Porto Rico 6
QA - Qatar 6
SC - Seychelles 6
NG - Nigeria 5
Totale 61.269
Salva come PNG Salva come JPEG
Città #
Southend 5.267
Singapore 3.315
Ashburn 2.037
Hong Kong 1.301
Chandler 1.183
San Jose 1.084
Milan 1.052
Beijing 1.026
Seattle 853
Princeton 691
Council Bluffs 657
Dallas 604
Wilmington 598
New York 593
Dublin 584
Frankfurt am Main 572
Fairfield 538
Los Angeles 514
Santa Clara 502
Jacksonville 499
Ho Chi Minh City 483
Ann Arbor 457
Bengaluru 402
Hanoi 397
Nanjing 371
Woodbridge 366
Hefei 338
Houston 326
Lauterbourg 314
Boardman 302
Cambridge 299
Toronto 288
Redmond 265
Dearborn 262
Buffalo 259
Guangzhou 246
Berlin 243
Warsaw 239
Des Moines 229
Moscow 228
Shanghai 220
Somerville 195
Tokyo 193
Mountain View 191
Serra 183
Ottawa 179
Sakarya 170
The Dalles 170
Bogotá 169
Andover 168
Jinan 168
Abidjan 165
Redwood City 165
Kent 164
Jakarta 143
Shenyang 140
Munich 137
Rome 136
Phoenix 134
Tianjin 131
São Paulo 128
Helsinki 126
Cangzhou 125
Athens 118
Columbus 110
Changsha 102
Nanchang 97
Hangzhou 90
Nuremberg 87
Da Nang 86
Brussels 82
Zhengzhou 82
Turin 78
Chicago 77
Seoul 72
Hebei 71
London 71
Istanbul 70
Norwalk 70
Haiphong 69
Naples 68
Fuzhou 65
Atlanta 61
Jiaxing 56
Shenzhen 56
Amsterdam 52
Medford 52
Montreal 50
Bühl 49
San Diego 48
Burlington 46
Margão 46
Quanzhou 46
Chengdu 44
Dong Ket 44
Johannesburg 42
Wuhan 42
Orem 41
San Francisco 41
Central District 40
Totale 35.905
Salva come PNG Salva come JPEG
Nome #
Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder 579
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 519
Heterozygous TREM2 mutations in frontotemporal dementia 425
Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion : a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits 405
New insights into the genetic etiology of Alzheimer's disease and related dementias 404
Age at symptom onset and death and disease duration in genetic frontotemporal dementia : an international retrospective cohort study 393
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses 345
Lag-time in Alzheimer's disease patients: A potential plasmatic oxidative stress marker associated with ApoE4 isoform 337
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 335
A functional variant in ERAP1 predisposes to multiple sclerosis 332
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 331
Frontotemporal dementia and its subtypes: a genome-wide association study 328
Influence of the Glu298Asp polymorphism of NOS3 on age at aonset and homocysteine levels in AD patients 325
Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer’s Disease 308
Usefulness of multi-parametric MRI for the investigation of posterior cortical atrophy 296
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 295
NOS3 Glu298Asp polymorphism is a risk factor for frontotemporal lobar degeneration 295
The T-786C NOS3 polymorphism in Alzheimer's disease : association and influence on gene expression 289
Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism 287
Role of hnRNP-A1 and miR-590-3p in neuronal death : genetics and expression analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration 285
Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy 280
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 279
Progranulin gene mutation scanning in Alzheimer's disease and frontotemporal lobar degeneration: functional and phenotypic correlations. 275
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 274
CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration 270
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 269
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 266
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis 265
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 260
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status 260
Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease 258
Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions : Frequency in a cohort of geriatric non-demented subjects 257
Total homocysteine levels in AD patients : analysis on different onset subgroups 256
E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis 255
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 255
Causal frontotemporal de generation mutations : a novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 255
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males 255
Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation 253
Novel exon 1 progranulin gene variations in Alzheimer's disease and frontotemporal lobar degeneration 252
Exosome determinants of physiological aging and age-related neurodegenerative diseases 252
Repetitive element hypermethylation in multiple sclerosis patients 251
Genetic and functional analysis of progranulin gene variants in Alzheimer's disease. 249
GRN variability contributes to sporadic frontotemporal lobar degeneration 249
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 249
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 248
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 247
IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment 246
Novel exon 1 progranulin gene variant in Alzheimer’s disease 244
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 244
Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes 242
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 241
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 235
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 234
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer’s disease : genetics and expression analysis 232
Association between VEGF gene and sporadic Alzheimer's disease. 231
Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations 231
Absence of mutations in TREM-2 coding region in early onset dementia 228
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort 227
Progranulin gene mutation scanning in Alzheimer's disease and Frontotemporal Lobar Degeneration: fuctional and phenotypic correlations 226
Progranulin gene mutation scanning and expression analysis in patients with Alzheimer's disease 225
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 224
Circulating miRNAs as potential biomarkers in Alzheimer's disease 224
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis 223
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 222
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 222
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease 221
ApoE e2 and e4 influence the susceptibility for Alzheimer’s disease but not other dementias 221
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease 221
Progranulin genetic variability in primary progressive multiple sclerosis. 221
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 221
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 221
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 220
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 219
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 219
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 219
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: A GENFI study 219
Progranulin gene variability in a population of 239 patients with primary progressive multiple sclerosis 218
Association of neuronal nitric oxide synthase C276T polymorphism with Azheimer's disease 217
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 217
Role of hnRNP-A1 and miR-590-3p in Neuronal Death : Genetics and Expression Analysis in Patients with Alzheimer Disease and Frontotemporal Lobar Degeneration 217
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay 217
Genetic and functional analysis of progranulin gene variants in patients with Alzheimer's disease 216
Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study 215
Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia 215
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 215
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 214
Progranulin gene mutation scanning in multiple sclerosis patients with cognitive impairment 214
Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population 214
Causal frontotemporal lobar degeneration mutations : a novel mutation in MAPT associated with non-fluent Progressive Aphasia phenotype 213
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 211
Neuronal Nitric Oxide Synthase C276T polymorphism increases the risk for Frontotemporal Lobar Degeneration 210
An emerging role for long non-coding RNA dysregulation in neurological disorders 210
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 209
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion : late-onset psychotic clinical presentation 209
Absence of mutations in TREM-2 coding region in patients with early onset dementia 208
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred 208
Effects of 1-month R--α--lipoic acid supplementation on humans oxidative status : A pilot study 208
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes 208
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer’s disease : genetic and expression analysis 207
CSF levels of IL-6, IL-11, LIF, A42, TAU and phospoTAU biomarkers in Alzheimer’s disease and Frontotemporal Lobar Degeneration 206
Totale 25.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.486
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021454 0 0 0 0 0 0 0 0 0 0 0 454
2021/20223.573 282 155 133 198 256 167 321 202 486 359 281 733
2022/20234.845 685 494 379 478 553 946 111 302 504 81 216 96
2023/20243.576 128 260 195 193 1.031 212 195 201 117 276 355 413
2024/20259.332 315 883 207 920 758 395 403 936 545 1.003 820 2.147
2025/202620.305 1.971 1.246 1.783 1.640 1.785 1.274 2.618 1.066 2.126 1.529 2.774 493
Totale 63.915